WuXi AppTec
Business Services · China · 10K+ Employees
View Company Info for Free
Overview
Headquarters
288 Free Trade Zone, Shanghai, Shanghai,...Phone Number
+86 2150461111Website
www.wuxiapptec.comRevenue
$6.4 BillionStock Symbol
WUXAYIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
4
1
2
About WuXi AppTec
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.Explore more
WuXi AppTec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is WuXi AppTec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once WuXi AppTec has new funding data
Earning: See what the market has to say on WuXi AppTec recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at WuXi AppTec
Product Launch: Get notified when WuXi AppTec launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if WuXi AppTec is spiking on competitors!
Check if WuXi AppTec has recently received funding, and reach out quickly before it becomes old news!
WuXi AppTec, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if WuXi AppTec had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
WuXi AppTec is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
WuXi AppTec is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about WuXi AppTec.
WuXi AppTec financials insights
Gather financial insights about WuXi AppTec, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$184.6M
2016
Debt
$1.5B
2024
Other Financing Round
$500M
WuXi AppTec Tech Stack
A closer look at the technologies used by WuXi AppTec
See more technologies
Most Recent Scoops
Person-Based
Capacity Planning
Person-Based
Spending/Investment, Capacity Planning, Manufacturing Operations
Hiring Plans
WuXi AppTec has more open roles in Medical & Health than it has had at any time in the past 12 months with an increased focus that include Pharmaceuticals, and Pharmaceuticals, and experience with Drug Development, Toxicology, Contract Research Organizations Management, General Scientific Knowledge, and Biomedical Sciences.
Hiring Plans
Open Position
Person-Based
WuXi AppTec News & Media
WuXi AppTec files complaint against U.S. DoD for linking it to Chinese military
June 11 (Reuters) - WuXi AppTec said on Thursday that it has filed a complaint at the United States District Court for the District of Columbia against the Department of Defense for including theAs New Drug Modalities Advance, WuXi AppTec Expands Global Capabilities for Peptides, Oligonucleotides and TPDs
SHANGHAI, SHANGHAI, CHINA, June 11, 2026 /EINPresswire.com/ -- The rapid rise of new therapeutic modalities — from peptides and oligonucleotides to targeted protein degraders (TPDs) and antibody-drug conjugates (ADCs) — is reshaping how medicines are …WuXi AppTec: A Global, Independent, Public Company Accountable to Shareholders, Customers, and Regulators
SAN DIEGO, CA, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- Over the past two decades, WuXi AppTec has grown alongside the global pharmaceutical and life sciences industry it serves. From a single lab to today’s multinational enterprise, the …WuXi AppTec: Global Partnerships Built on Strict Compliance and Transparency
SAN DIEGO, CA, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- As a global company operating in a highly regulated pharmaceutical and life sciences industry, WuXi AppTec places compliance, transparency, and responsible business conduct at the center …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding WuXi AppTec
Sign Up For FreeTo access detailed company insights
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi... Read More
